diabetic retinopathy
Conditions
Interventions
intravitreal conbercept group vs control group:intravitreal conbercept injection
Sponsors
The First People's Hospital of Yunnan Province
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: The study population consisted of male or female patients aged >=18 years with type 1 or 2 DM (per American Diabetes Association or World Health Organization guidelines), hemoglobin (Hb) A1c <=10%, and visual loss only due to non-absorbent VH, fibrovascular proliferation with vitreoretinal adhesions or tractional retinal detachment (TRD) depended on clinical ocular findings and accessory examinations who had to undergo vitrectomy.
Exclusion criteria
Exclusion criteria: Key exclusion criteria were history of coagulopathy, hypertension and stroke or transient ischemic attack; intraocular treatment with corticosteroids, anti-VEGF or intraocular surgery at any time; confirmed intraocular pressure (IOP) >=21 mmHg, glaucoma or iris neovascularization in either eye; severe retinopathy with long-acting gas or silicone oil usage during surgery; a follow-up period of fewer than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BCVA;recurrent vitreous hemorrhage;vitreous clear-up time; | — |
Countries
china
Contacts
Public ContactXiaochun Yang
Outcome results
None listed